Douglas V. Faller, MD, PhD

Professor, Medicine

Douglas Faller
(617) 638-4173
72 E. Concord St Silvio Conte (K)

Other Positions

  • Professor, Pathology & Laboratory Medicine, Boston University School of Medicine
  • Active Staff Privileges, Hematology & Medical Oncology, Medicine, Boston Medical Center


  • Harvard University, MD
  • Massachusetts Institute of Technology, PhD
  • Massachusetts Institute of Technology, BS


  • Published on 1/5/2018

    Hari P, Lin HM, Asche CV, Ren J, Yong C, Luptakova K, Faller DV, Sanchorawala V. Treatment patterns and health care resource utilization among patients with relapsed/refractory systemic light chain amyloidosis. Amyloid. 2018 Jan 05; 1-7. PMID: 29303358.

    Read at: PubMed
  • Published on 12/1/2017

    Moos WH, Faller DV, Glavas IP, Harpp DN, Irwin MH, Kanara I, Pinkert CA, Powers WR, Steliou K, Vavvas DG, Kodukula K. Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future. Biores Open Access. 2017; 6(1):169-181. PMID: 29291141.

    Read at: PubMed
  • Published on 10/1/2017

    Kodukula K, Faller DV, Harpp DN, Kanara I, Pernokas J, Pernokas M, Powers WR, Soukos NS, Steliou K, Moos WH. Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something. Biores Open Access. 2017; 6(1):123-132. PMID: 29098118.

    Read at: PubMed
  • Published on 4/11/2017

    Lin HM, Gao X, Cooke CE, Berg D, Labotka R, Faller DV, Seal B, Hari P. Disease burden of systemic light-chain amyloidosis: a systematic literature review. Curr Med Res Opin. 2017 Jun; 33(6):1017-1031. PMID: 28277869.

    Read at: PubMed
  • Published on 10/31/2016

    Faller DV, Castaneda SA, Zhou D, Vedamony M, Newburger PE, White GL, Kosanke S, Plett PA, Orschell CM, Boosalis MS, Perrine SP. An oral HemokineTM, a-methylhydrocinnamate, enhances myeloid and neutrophil recovery following irradiation in vivo. Blood Cells Mol Dis. 2017 Mar; 63:1-8. PMID: 27888688.

    Read at: PubMed
  • Published on 10/20/2016

    Moos WH, Pinkert CA, Irwin MH, Faller DV, Kodukula K, Glavas IP, Steliou K. Epigenetic Treatment of Persistent Viral Infections. Drug Dev Res. 2017 Feb; 78(1):24-36. PMID: 27761936.

    Read at: PubMed
  • Published on 5/1/2016

    Moos WH, Faller DV, Harpp DN, Kanara I, Pernokas J, Powers WR, Steliou K. Microbiota and Neurological Disorders: A Gut Feeling. Biores Open Access. 2016; 5(1):137-45. PMID: 27274912.

    Read at: PubMed
  • Published on 2/21/2016

    Irwin MH, Moos WH, Faller DV, Steliou K, Pinkert CA. Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases. Drug Dev Res. 2016 May; 77(3):109-23. PMID: 26899010.

    Read at: PubMed
  • Published on 2/21/2016

    Moos WH, Maneta E, Pinkert CA, Irwin MH, Hoffman ME, Faller DV, Steliou K. Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia. Drug Dev Res. 2016 Mar; 77(2):53-72. PMID: 26899191.

    Read at: PubMed
  • Published on 12/29/2015

    Boosalis MS, Sangerman JI, White GL, Wolf RF, Shen L, Dai Y, White E, Makala LH, Li B, Pace BS, Nouraie M, Faller DV, Perrine SP. Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice. PLoS One. 2015; 10(12):e0144660. PMID: 26713848.

    Read at: PubMed

View 264 more publications: View full profile at BUMC

View all profiles